Tobacco Stocks Jump 5% on FDA Guidance

The U.S. FDA released updated enforcement priorities, stating it will not prioritize actions against e‑vapour and nicotine‑pouch products with pending pre‑market applications.
Shares of BTI rose 4.87%, PM climbed 4.26%, and MO increased 2.57% following the guidance announcement.
Morgan Stanley and Jefferies analysts see the guidance as positive for tobacco, especially PM and BAT, with upside for MO and JT.
The FDA will maintain a public list of non‑prioritized products, but unauthorized items remain illegal.